Back to Journals » Infection and Drug Resistance » Volume 1

Current and novel antibiotics against resistant Gram-positive bacteria

Authors Federico Perez, Robert A Salata, Robert A Bonomo

Published 9 September 2008 Volume 2008:1 Pages 27—44

DOI https://doi.org/10.2147/IDR.S3545

Review by Single-blind

Peer reviewer comments 2

Federico Perez1, Robert A Salata1, Robert A Bonomo2

1Division of Infectious Diseases and HIV Medicine, University Hospitals Case Medical Center, Cleveland OH, USA; 2Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH, USA

Abstract: The challenge posed by resistance among Gram-positive bacteria, epitomized by methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE) and vancomycin-intermediate and -resistant S. aureus (VISA and VRSA) is being met by a new generation of antimicrobials. This review focuses on the new β-lactams with activity against MRSA (ceftobiprole and ceftaroline) and on the new glycopeptides (oritavancin, dalbavancin, and telavancin). It will also consider the role of vancomycin in an era of existing alternatives such as linezolid, daptomycin and tigecycline. Finally, compounds in early development are described, such as iclaprim, friulimicin, and retapamulin, among others.

Keywords: Gram-positive bacteria, vancomycin, anti-MRSA cephalosporins, lipoglycopeptides, daptomycin, linezolid, tigecycline

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Current perspectives on the spread of dengue in India

Gupta E, Ballani N

Infection and Drug Resistance 2014, 7:337-342

Published Date: 11 December 2014

Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis

Dookie N, Sturm AW, Moodley P

Infection and Drug Resistance 2014, 7:223-228

Published Date: 19 August 2014

Current management options for latent tuberculosis: a review

Norton BL, Holland DP

Infection and Drug Resistance 2012, 5:163-173

Published Date: 29 November 2012

A necrotic lung ball caused by co-infection with Candida and Streptococcus pneumoniae

Yokoyama T, Sasaki J, Matsumoto K, Koga C, Ito Y, Kaku Y, Tajiri M, Natori H, Hirokawa M

Infection and Drug Resistance 2011, 4:221-224

Published Date: 15 December 2011

Review of oral cholera vaccines: efficacy in young children

Masuet Aumatell C, Ramon Torrell JM, Zuckerman JN

Infection and Drug Resistance 2011, 4:155-160

Published Date: 14 September 2011

Characterization and antibiotic susceptibility of Listeria monocytogenes isolated from poultry and red meat in Morocco

Hayat Ennaji, Mohammed Timinouni, My Mustapha Ennaji, Mohammed Hassar, Nozha Cohen

Infection and Drug Resistance 2008, 1:45-50

Published Date: 28 September 2008

Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin-containing regimen

Christy A Beneri, David P Nicolau, Howard S Seiden, Lorry G Rubin

Infection and Drug Resistance 2008, 1:9-11

Published Date: 12 August 2008

Deep neck abscess: an analysis of microbial etiology and the effectiveness of antibiotics

Shih-Wei Yang, Ming-Hsun Lee, Lai-Chu See, Shu-Huan Huang, Tsung-Ming Chen, Tai-An Chen

Infection and Drug Resistance 2008, 1:1-8

Published Date: 7 July 2008